Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors
Authors:
- 29 June 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (25) , 3241-3247
Abstract
Background —The NHLBI Post Coronary Artery Bypass Graft trial (Post CABG) showed that aggressive compared with moderate lowering of low-density lipoprotein-cholesterol (LDL-C) decreased obstructive changes in saphenous vein grafts (SVGs) by 31%. 1 Using lovastatin and cholestyramine when necessary, the annually determined mean LDL-C level ranged from 93 to 97 mg/dL in aggressively treated patients and from 132 to 136 mg/dL in the others ( P Methods and Results —The present study evaluated the treatment effect in subgroups defined by age, gender, and selected coronary heart disease (CHD) risk factors, ie, smoking, hypertension, diabetes mellitus, high-density lipoprotein cholesterol (HDL-C) Conclusions —Aggressive LDL-C lowering delays progression of atherosclerosis in SVGs irrespective of gender, age, and certain risk factors for CHD.Keywords
This publication has 22 references indexed in Scilit:
- Delayed progression of atherosclerosis in coronary bypass grafts is similar in women compared to men following aggressive cholesterol lowering despite more frequent risk factors: post CABG trialJACC, 1998
- Delayed Progression of Atherosclerosis in Coronary Bypass Grafts Is Similar in Women Compared to Men Following Aggressive Cholesterol Lowering Despite More Frequent Risk Factors: Post CABG TrialJACC, 1998
- Reducing the risk of coronary events: Evidence from the Scandinavian Simvastatin survival study (4S)The American Journal of Cardiology, 1995
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Women in the POSCH Trial Effects of Aggressive Cholesterol Modification in Women With Coronary Heart DiseaseAnnals of Surgery, 1992
- Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)The Lancet, 1992
- Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with menThe Lancet, 1992
- Can lifestyle changes reverse coronary heart disease?The Lancet, 1990
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling projectJournal of Chronic Diseases, 1978